Robert Besthof, Chief Comm. & Patient Officer at NRX Pharmaceuticals, Inc. (NRXP), sold 40,000 shares at $11.76 ($470K) on 2021-09-15, disclosed to the SEC on 2021-11-02.
Open-market sale of $470k NRXP by Chief Comm. & Patient Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.